LPA and metabolic syndrome: In contrast, the higher Lp(a) levels in obese controls hint at a complex interplay where Lp(a) may not directly correlate with MI risk in individuals with multiple metabolic risk factors, potentially due to the overwhelming impact of conditions like metabolic syndrome or other lipid abnormalities [2].